Clinical Trials Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trial Research
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
August 27th, 2007
MAP Pharmaceuticals, Inc. announced that Stephen B. Shrewsbury, M.B. Ch.B., has been promoted to Chief Medical Officer, a newly created position. Dr. Shrewsbury most recently served as the company's Vice President, Clinical and Regulatory Affairs. He will be the principal medical advisor and head of all medical staff, responsible for overseeing all medical and business components of the clinical development process, strategy and clinical plans to optimize the advancement of the Company's technology, and serving as the Company's medical spokesperson. "Steve's scientific vision, personal contributions and exceptional leadership have played an instrumental role in moving...
Source: Clinical Trials Week (2007-08-27)
|
